Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

1972320 citationsJournal Articlebronze Open Access

Authors

G. M. Besser · Institute for Research and Development

Lynn Parke · Institute for Research and Development

C.R.W. Edwards · Institute for Research and Development

I. A. Forsyth · Institute for Research and Development

A. S. McNeilly · Institute for Research and Development

Abstract

In five patients with inappropriate lactation and amenorrhoea or impotence brom-ergocryptine was found to suppress the lactation and to diminish the raised plasma prolactin levels. The responses to treatment suggest that there may be an inverse relationship between prolactin secretion and gonadotrophin secretion in man.

Topics & Keywords

Neuroendocrine regulation and behavior Growth Hormone and Insulin-like Growth Factors Hypothalamic control of reproductive hormones

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 3, Issue 5828, pp. 669-672

DOI: 10.1136/bmj.3.5828.669

Field-Weighted Citation Impact: 37.46